Change Language

Select Language

Press Release:

Global Next-Generation Sequencing (NGS) Market to Grow at 19.5% During 2022-2027, Bolstered by Widespread Adoption of Genome Mapping Programs

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 40.25 Billion by 2027, exhibiting at a CAGR of 19.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics. 

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Next-Generation Sequencing (NGS) Market Trends and Drivers:

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the global next-generation sequencing market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global next-generation sequencing (NGS) market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.

Breakup by Sequencing Type:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others
     

Breakup by Product Type:

  • Instruments
  • Reagents and Consumables
  • Software and Services


Breakup by Technology:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others
     

Breakup by Application:

  • Biomarker and Cancer
  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others
     

Breakup by End-User:

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Sequencing Type, Product Type, Technology, Application, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V. and GenapSys Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Next-Generation Sequencing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Sequencing Type
    6.1    Whole Genome Sequencing
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Targeted Resequencing
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Whole Exome Sequencing
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    RNA Sequencing
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    CHIP Sequencing
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    De Novo Sequencing
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Methyl Sequencing
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Others
        6.8.1 Market Trends
        6.8.2 Market Forecast
7   Market Breakup by Product Type
    7.1    Instruments
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Reagents and Consumables
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Software and Services
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Technology
    8.1    Sequencing by Synthesis
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ion Semiconductor Sequencing
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Single-Molecule Real-Time Sequencing
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Nanopore Sequencing
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Application
    9.1    Biomarker and Cancer
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Drug Discovery and Personalized Medicine
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Genetic Screening
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Diagnostics
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Agriculture and Animal Research
        9.5.1 Market Trends
        9.5.2 Market Forecast
    9.6    Others
        9.6.1 Market Trends
        9.6.2 Market Forecast
10  Market Breakup by End-User
    10.1    Academic Institutes & Research Centers
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Hospitals & Clinics
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Pharmaceutical & Biotechnology Companies
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Others
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12  SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis
    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15  Price Indicators
16  Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Agilent Technologies Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio 
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Becton Dickinson and Company
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
           16.3.2.4 SWOT Analysis
        16.3.3    10x Genomics
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio 
        16.3.4    BGI Group
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
        16.3.5    Eurofins Scientific
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio 
        16.3.6    F. Hoffmann-La Roche AG
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio 
           16.3.6.3 Financials 
        16.3.7    Illumina Inc.
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio 
           16.3.7.3 Financials
           16.3.7.4 SWOT Analysis
        16.3.8    Genewiz
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
        16.3.9    Macrogen Inc.
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
         16.3.10    Oxford Nanopore Technologies
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio 
           16.3.10.3 Financials
           16.3.10.4 SWOT Analysis
        16.3.11    Pacific Biosciences
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
        16.3.12    Perkinelmer Inc.
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio
           16.3.12.3 Financials
           16.3.12.4 SWOT Analysis
        16.3.13    Thermo Fisher Scientific Inc.
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio
           16.3.13.3 Financials 
           16.3.13.4 SWOT Analysis
        16.3.14    Qiagen N.V.
           16.3.14.1 Company Overview
           16.3.14.2 Product Portfolio
           16.3.14.3 Financials 
           16.3.14.4 SWOT Analysis
        16.3.15    Genapsys Inc.
           16.3.15.1 Company Overview
           16.3.15.2 Product Portfolio
 
List of Figures

Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2021
Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2021
Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2021
Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2021
Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2021
Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million US$), 2016 & 2021
Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
Figure 112: Global: Next-Generation Sequencing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2022-2027
Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Next-Generation Sequencing Market Structure
Table 9: Global: Next-Generation Sequencing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global next-generation sequencing (NGS) market was valued at US$ 13.82 Billion in 2021.

We expect the global next-generation sequencing (NGS) market to exhibit a CAGR of 19.5% during 2022-
2027.

The growing adoption of Next-Generation Sequencing (NGS) for determining the sequence of
nucleotides in a section of the DNA owing to its precise results with high accuracy and speed, is currently
driving the global next-generation sequencing (NGS) market.

The sudden outbreak of the COVID-19 pandemic has led to an increasing demand for next generation
sequencing process as it assists in identifying the mutations and transmission routes in the body that is
causing the spread of the coronavirus infection.

Based on the sequencing type, the global next-generation sequencing (NGS) market can be segmented
into whole genome sequencing, targeted resequencing, whole exome sequencing, RNA sequencing,
CHIP sequencing, De Novo Sequencing, methyl sequencing, and others. Currently, targeted
resequencing exhibits a clear dominance in the market.

Based on the product type, the global next-generation sequencing (NGS) market has been segregated
into instruments, reagents and consumables, and software and services. Among these, reagents and
consumables currently account for the majority of the total market share.

Based on the technology, the global next-generation sequencing (NGS) market can be categorized into
sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing,
nanopore sequencing, and others. Currently, sequencing by synthesis exhibits a clear dominance in the
market.

Based on the application, the global next-generation sequencing (NGS) market can be bifurcated into
biomarker and cancer, drug discovery and personalized medicine, genetic screening, diagnostics,
agriculture and animal research and others. Among these, biomarker and cancer application represents
the largest market share.

Based on the end-user, the global next-generation sequencing (NGS) market has been divided into
academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies,
and others. Currently, academic institutes & research centers account for the majority of the global
market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global next-generation sequencing (NGS) market include Agilent
Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F.
Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific
Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Endpoint Security Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Mainframe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Video Surveillance Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Serious Games Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Serverless Architecture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links